search
Back to results

Treatment of Fibromyalgia With Recovery Factors

Primary Purpose

Fibromyalgia, Chronic Fatigue Syndrome

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Recovery Factors
Sponsored by
Practitioners Alliance Network
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Fibromyalgia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Meet the ACR 2010 Amended Fibromyalgia Diagnostic Criteria or CFS CDC criteria; Score 5 or less on Energy VAS

Exclusion Criteria:

Under 18 Pregnant Other severe complicating conditions

-

Sites / Locations

  • Jacob Teitelbaum MD

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Assessing clinical outcomes

Arm Description

Nutritional support with Recovery Factors

Outcomes

Primary Outcome Measures

Composite VAS
Composite of VAS for Fatigue, sleep, cognition, pain and overall well being

Secondary Outcome Measures

FIQ-R
Fibromyalgia Impact Questionnaire

Full Information

First Posted
May 6, 2020
Last Updated
October 3, 2021
Sponsor
Practitioners Alliance Network
search

1. Study Identification

Unique Protocol Identification Number
NCT04381780
Brief Title
Treatment of Fibromyalgia With Recovery Factors
Official Title
Treatment of Fibromyalgia With a Unique Polypeptide Nutritional Support
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
May 6, 2020 (Actual)
Primary Completion Date
December 1, 2020 (Actual)
Study Completion Date
January 15, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Practitioners Alliance Network

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Treatment of Fibromyalgia and CFS with Recovery Factors
Detailed Description
Use of a unique oral porcine peptide nutritional supplement in those meeting ACR 2010(amended) diagnostic criteria for Fibromyalgia or CDC Criteria for CFS

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fibromyalgia, Chronic Fatigue Syndrome

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Open pilot study
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Assessing clinical outcomes
Arm Type
Experimental
Arm Description
Nutritional support with Recovery Factors
Intervention Type
Dietary Supplement
Intervention Name(s)
Recovery Factors
Intervention Description
A unique porcine serum based polypeptide nutritional support
Primary Outcome Measure Information:
Title
Composite VAS
Description
Composite of VAS for Fatigue, sleep, cognition, pain and overall well being
Time Frame
6 weeks
Secondary Outcome Measure Information:
Title
FIQ-R
Description
Fibromyalgia Impact Questionnaire
Time Frame
1 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Meet the ACR 2010 Amended Fibromyalgia Diagnostic Criteria or CFS CDC criteria; Score 5 or less on Energy VAS Exclusion Criteria: Under 18 Pregnant Other severe complicating conditions -
Facility Information:
Facility Name
Jacob Teitelbaum MD
City
Kailua
State/Province
Hawaii
ZIP/Postal Code
96740
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Treatment of Fibromyalgia With Recovery Factors

We'll reach out to this number within 24 hrs